138 related articles for article (PubMed ID: 19264685)
1. Serotonin rising--the bone, brain, bowel connection.
Rosen CJ
N Engl J Med; 2009 Mar; 360(10):957-9. PubMed ID: 19264685
[No Abstract] [Full Text] [Related]
2. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum.
Yadav VK; Ryu JH; Suda N; Tanaka KF; Gingrich JA; Schütz G; Glorieux FH; Chiang CY; Zajac JD; Insogna KL; Mann JJ; Hen R; Ducy P; Karsenty G
Cell; 2008 Nov; 135(5):825-37. PubMed ID: 19041748
[TBL] [Abstract][Full Text] [Related]
3. The two faces of serotonin in bone biology.
Ducy P; Karsenty G
J Cell Biol; 2010 Oct; 191(1):7-13. PubMed ID: 20921133
[TBL] [Abstract][Full Text] [Related]
4. Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway.
Glass DA; Karsenty G
Curr Top Dev Biol; 2006; 73():43-84. PubMed ID: 16782455
[TBL] [Abstract][Full Text] [Related]
5. LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders.
Levasseur R; Lacombe D; de Vernejoul MC
Joint Bone Spine; 2005 May; 72(3):207-14. PubMed ID: 15850991
[TBL] [Abstract][Full Text] [Related]
6. Wnt signaling: a key regulator of bone mass.
Baron R; Rawadi G; Roman-Roman S
Curr Top Dev Biol; 2006; 76():103-27. PubMed ID: 17118265
[TBL] [Abstract][Full Text] [Related]
7. Lrp5 and bone formation : A serotonin-dependent pathway.
Yadav VK; Ducy P
Ann N Y Acad Sci; 2010 Mar; 1192():103-9. PubMed ID: 20392224
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone receptor directly interacts with dishevelled to regulate beta-Catenin signaling and osteoclastogenesis.
Romero G; Sneddon WB; Yang Y; Wheeler D; Blair HC; Friedman PA
J Biol Chem; 2010 May; 285(19):14756-63. PubMed ID: 20212039
[TBL] [Abstract][Full Text] [Related]
9. Regulation of bone mass by serotonin: molecular biology and therapeutic implications.
Karsenty G; Yadav VK
Annu Rev Med; 2011; 62():323-31. PubMed ID: 21073335
[TBL] [Abstract][Full Text] [Related]
10. The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of the skeletal effects of low-density lipoprotein receptor-related protein 5 (LRP5).
Warden SJ; Robling AG; Haney EM; Turner CH; Bliziotes MM
Bone; 2010 Jan; 46(1):4-12. PubMed ID: 19591966
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton.
Baron R; Rawadi G
Endocrinology; 2007 Jun; 148(6):2635-43. PubMed ID: 17395698
[TBL] [Abstract][Full Text] [Related]
12. Serotonin rising.
Anderson GM; Cook EH; Blakely RD
N Engl J Med; 2009 Jun; 360(24):2580; author reply 2581-2. PubMed ID: 19516042
[No Abstract] [Full Text] [Related]
13. [The role of Wnt/β-catenin pathway and LRP5 protein in metabolism of bone tissue and osteoporosis etiology].
Wolski H; Drwęska-Matelska N; Seremak-Mrozikiewicz A; Łowicki Z; Czerny B
Ginekol Pol; 2015 Apr; 86(4):311-4. PubMed ID: 26117992
[TBL] [Abstract][Full Text] [Related]
14. miR-409-5p negatively regulates Wnt/Beta catenin signaling pathway by targeting Lrp-8.
Prakash R; John AA; Singh D
J Cell Physiol; 2019 Dec; 234(12):23507-23517. PubMed ID: 31165485
[TBL] [Abstract][Full Text] [Related]
15. Very low density lipoprotein receptor, a negative regulator of the wnt signaling pathway and choroidal neovascularization.
Chen Y; Hu Y; Lu K; Flannery JG; Ma JX
J Biol Chem; 2007 Nov; 282(47):34420-8. PubMed ID: 17890782
[TBL] [Abstract][Full Text] [Related]
16. When the gut talks to bone.
Long F
Cell; 2008 Nov; 135(5):795-6. PubMed ID: 19041744
[TBL] [Abstract][Full Text] [Related]
17. Patients with high-bone-mass phenotype owing to Lrp5-T253I mutation have low plasma levels of serotonin.
Frost M; Andersen TE; Yadav V; Brixen K; Karsenty G; Kassem M
J Bone Miner Res; 2010 Mar; 25(3):673-5. PubMed ID: 20200960
[TBL] [Abstract][Full Text] [Related]
18. The Wnt signaling pathway and bone metabolism.
Johnson ML; Kamel MA
Curr Opin Rheumatol; 2007 Jul; 19(4):376-82. PubMed ID: 17551370
[TBL] [Abstract][Full Text] [Related]
19. [Cytokines in bone diseases. Wnt signaling and osteoporosis-pseudoglioma syndrome].
Ozono K
Clin Calcium; 2010 Oct; 20(10):1520-5. PubMed ID: 20890034
[TBL] [Abstract][Full Text] [Related]
20. Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5.
Frost M; Andersen T; Gossiel F; Hansen S; Bollerslev J; van Hul W; Eastell R; Kassem M; Brixen K
J Bone Miner Res; 2011 Aug; 26(8):1721-8. PubMed ID: 21351148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
